col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


19 Results       Page 1

 [1] 
Elsevier: Advanced Drug Delivery Reviews
  original article Date Title Authors   All Authors
1 [GO] 2022―Aug―26 Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000] Samagra Jain, Abhijeet Venkataraman, Marissa E. Wechsler, Nicholas A. Peppas
2 [GO] 2021―Nov―20 Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic Vladimir A. Ljubimov, Arshia Ramesh, Saya Davani, Moise Danielpour, Joshua J. Breunig, Keith L. Black
3 [GO] 2021―Oct―11 Messenger RNA-based Vaccines: Past, Present, and Future Directions in the Context of the COVID-19 Pandemic Samagra Jain, Abhijeet Venkataraman, Marissa E. Wechsler, Nicholas A. Peppas
4 [GO] 2021―Jun―26 Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19 Danielle Brain, Alex Plant-Hately, Bethany Heaton, Usman Arshad, Christopher David, Christian Hedrich, et al. (+2)
5 [GO] 2021―Feb―18 Adaptive immune responses to SARS-CoV-2 Donald Forthal
6 [GO] 2021―Feb―07 Current and prospective computational approaches and challenges for developing COVID-19 vaccines Woochang Hwang, Winnie Lei, Nicholas M Katritsis, Méabh MacMahon, Kathryn Chapman, Namshik Han
7 [GO] 2021―Feb―03 Microarray patches enable the development of skin-targeted vaccines against COVID-19 Emrullah Korkmaz, Stephen C. Balmert, Tina L. Sumpter, Cara Donahue Carey, Geza Erdos, Louis D. Falo
8 [GO] 2021―Jan―29 COVID-19: An unprecedented challenge and an opportunity for change Young Jik Kwon, Donald Forthal
9 [GO] 2021―Jan―20 SARS-CoV-2 vaccines in advanced clinical trials: where do we stand Saborni Chakraborty, Vamsee Mallajosyula, Cristina M. Tato, Gene S. Tan, Taia T. Wang
10 [GO] 2021―Jan―18 In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives Muhammad Saqib Sohail, Syed Faraz Ahmed, Ahmed Abdul Q귮r, Matthew R. McKay
11 [GO] 2021―Jan―11 Nanocarrier Vaccines for SARS-CoV-2 Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, et al. (+21)
12 [GO] 2021―Jan―08 Advances in gene-based vaccine platforms to address the COVID-19 pandemic Deborah Pushparajah, Salma Jimenez, Shirley Wong, Hibah Alattas, Nafiseh Nafissi, Roderick A. Slavcev
13 [GO] 2021―Jan―08 Recombinant protein vaccines, a proven approach against coronavirus pandemics Jeroen Pollet, Wen-Hsiang Chen, Ulrich Strych
14 [GO] 2020―Dec―24 COVID-19 vaccines: The status and perspectives in delivery points of view Jee Young Chung, Melissa N. Thone, Young Jik Kwon
15 [GO] 2020―Dec―17 Non-viral COVID-19 vaccine delivery systems Kyung Soo Park, Xiaoqi Sun, Marisa E. Aikins, James J. Moon
16 [GO] 2020―Dec―13 Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie
17 [GO] 2020―Dec―09 Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy Carlos Cruz-Teran, Karthik Tiruthani, Morgan McSweeney, Alice Ma, Raymond Pickles, Samuel K. Lai
18 [GO] 2020―Nov―13 Peptide and peptide-based inhibitors of SARS-CoV-2 entry Desiree Schütz, Yasser B. Ruiz-Blanco, Jan Münch, Frank Kirchhoff, Elsa Sanchez-Garcia, Janis A. Müller
19 [GO] 2020―Nov―01 Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic Jenny K.W. Lam, Chucky C.K. Cheung, Michael Y.T. Chow, Emily Harrop, Susie Lapwood, Stephen I.G. Barclay, Ian C.K. Wong
 [1] 

19 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec